324 related articles for article (PubMed ID: 20069871)
1. [Bacteriophage lysins: progress and perspective--a review].
Wang Y; Lu C
Wei Sheng Wu Xue Bao; 2009 Oct; 49(10):1277-81. PubMed ID: 20069871
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophage lytic enzymes: novel anti-infectives.
Fischetti VA
Trends Microbiol; 2005 Oct; 13(10):491-6. PubMed ID: 16125935
[TBL] [Abstract][Full Text] [Related]
3. LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci.
Donovan DM; Foster-Frey J
FEMS Microbiol Lett; 2008 Oct; 287(1):22-33. PubMed ID: 18673393
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an endolysin, LysBPS13, from a Bacillus cereus bacteriophage.
Park J; Yun J; Lim JA; Kang DH; Ryu S
FEMS Microbiol Lett; 2012 Jul; 332(1):76-83. PubMed ID: 22524239
[TBL] [Abstract][Full Text] [Related]
5. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria.
Lim JA; Shin H; Heu S; Ryu S
J Microbiol Biotechnol; 2014 Jun; 24(6):803-11. PubMed ID: 24690638
[TBL] [Abstract][Full Text] [Related]
6. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.
Lai MJ; Lin NT; Hu A; Soo PC; Chen LK; Chen LH; Chang KC
Appl Microbiol Biotechnol; 2011 Apr; 90(2):529-39. PubMed ID: 21264466
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophage endolysins as a novel class of antibacterial agents.
Borysowski J; Weber-Dabrowska B; Górski A
Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
[TBL] [Abstract][Full Text] [Related]
9. Endolysins as antimicrobials.
Nelson DC; Schmelcher M; Rodriguez-Rubio L; Klumpp J; Pritchard DG; Dong S; Donovan DM
Adv Virus Res; 2012; 83():299-365. PubMed ID: 22748813
[TBL] [Abstract][Full Text] [Related]
10. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
Vázquez R; García E; García P
J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
[TBL] [Abstract][Full Text] [Related]
11. [Phage lytic enzymes--new hope in battle against bacterial infections].
Niczyporuk JS; Bartoszcze M
Przegl Epidemiol; 2007; 61(4):713-21. PubMed ID: 18572503
[TBL] [Abstract][Full Text] [Related]
12. Research Progress on Strategies for Improving the Enzyme Properties of Bacteriophage Endolysins.
Wang Y; Wang X; Liu X; Lin B
J Microbiol Biotechnol; 2024 Jun; 34(6):1189-1196. PubMed ID: 38693045
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
Mirski T; Lidia M; Nakonieczna A; Gryko R
Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus.
Linden SB; Zhang H; Heselpoth RD; Shen Y; Schmelcher M; Eichenseher F; Nelson DC
Appl Microbiol Biotechnol; 2015 Jan; 99(2):741-52. PubMed ID: 25038926
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of bacteriophage lytic proteins against Streptococcus pneumoniae in the chloroplast of Chlamydomonas reinhardtii.
Stoffels L; Taunt HN; Charalambous B; Purton S
Plant Biotechnol J; 2017 Sep; 15(9):1130-1140. PubMed ID: 28160380
[TBL] [Abstract][Full Text] [Related]
16. Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain.
Becker SC; Foster-Frey J; Stodola AJ; Anacker D; Donovan DM
Gene; 2009 Aug; 443(1-2):32-41. PubMed ID: 19422893
[TBL] [Abstract][Full Text] [Related]
17. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
[TBL] [Abstract][Full Text] [Related]
18. Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; Exhibits broad activity against multi drug resistant pathogens.
Basit A; Qadir S; Qureshi S; Rehman SU
Enzyme Microb Technol; 2021 Sep; 149():109846. PubMed ID: 34311883
[TBL] [Abstract][Full Text] [Related]
19. A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability.
Swift SM; Seal BS; Garrish JK; Oakley BB; Hiett K; Yeh HY; Woolsey R; Schegg KM; Line JE; Donovan DM
Viruses; 2015 Jun; 7(6):3019-34. PubMed ID: 26075507
[TBL] [Abstract][Full Text] [Related]
20. Peptidoglycan hydrolase fusions maintain their parental specificities.
Donovan DM; Dong S; Garrett W; Rousseau GM; Moineau S; Pritchard DG
Appl Environ Microbiol; 2006 Apr; 72(4):2988-96. PubMed ID: 16598006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
